/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Aquantia Announces First Quarter 2019 Results
SAN JOSE, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24AQ&src=ctag” target=”_blank”gt;$AQlt;/agt; lt;a href=”https://twitter.com/hashtag/80211ax?src=hash” target=”_blank”gt;#80211axlt;/agt;–Aquantia Corp., (NYSE: AQ), a leader in high-speed, Multi-Gigabit
Ethernet connectivity solutions, today announced financial results for
its first quarter ended March 31, 2019.
First quarter 2019 Summary:
-
Revenue for the three months ended March 31, 2019 of $17.0 million, a
decrease of 42 percent sequentially and 40 percent year-over-year; -
Gross margin of 53 percent for the three months ended March 31, 2019,
compared to 57 percent for the three months ended December 31, 2018; -
Operating loss of $13.2 million for the three months ended March 31,
2019, and non-GAAP operating loss of $10.8 million for the same
period; and -
Net loss per diluted share of $0.37 for the three months ended March
31, 2019, and non-GAAP net loss per diluted share of $0.31 for the
same period.
First Quarter 2019 Results
Total revenue for the first quarter 2019 was $17.0 million, a decrease
of 42 percent compared to $29.1 million in the prior quarter, and a
decrease of 40 percent compared to $28.4 million in the first quarter
2018.
Gross profit for the first quarter 2019 was $9.0 million, or 53 percent
of revenue, compared to $15.7 million, or 54 percent of revenue, in the
prior quarter, and $16.1 million, or 57 percent of revenue, in the first
quarter 2018. Operating expenses in the first quarter 2019 were $22.2
million, compared to $21.1 million in the prior quarter and $17.9
million in the first quarter 2018.
Loss from operations for the first quarter 2019 was $13.2 million, or 78
percent of revenue, compared to $5.3 million, or 18 percent of revenue,
in the prior quarter, and $1.7 million, or 6 percent of revenue, in the
first quarter 2018. Non-GAAP loss from operations for the first quarter
2019 was $11.0 million, or 64 percent of revenue, compared to $3.1
million, 11 percent of revenue in the prior quarter and $0.8 million, 3
percent of revenue in the first quarter 2018.
First quarter 2019 net loss was $13.1 million, or a loss of $0.37 per
diluted share, compared to fourth quarter 2018 net loss of $5.5 million,
or a loss of $0.16 per diluted share, and first quarter 2018 net loss of
$1.4 million, or $0.04 per diluted share.
Non-GAAP net loss for the first quarter 2019 was $10.8 million, or a
loss of $0.31 per diluted share. This compares to non-GAAP net loss of
$3.2 million, or a loss of $0.09 per diluted share for the fourth
quarter 2018 and non-GAAP net loss of $0.4 million, or $0.01 per diluted
share for the first quarter 2018.
“We experienced weaker demand in the first quarter than we had
anticipated as we saw several customers push out purchase orders,” said
Faraj Aalaei, Chairman and CEO. “Our technical leadership remains strong
and we are encouraged by our customers’ forecast as we see the
deployment of 802.11ax in the Enterprise and our 10G PON design wins
with Asian service providers driving our revenue growth throughout the
year.”
Balance Sheet
Cash, cash equivalents and short-term investments totaled $62.4 million
at March 31, 2019, compared to $67.4 million at December 31, 2018. The
decrease of $5.0 million was primarily for our operating activities.
Non-GAAP Financial Measures
In addition to GAAP reporting, the Company provides non-GAAP financial
measures on loss from operations and net loss. These non-GAAP financial
measures exclude the income statement effects of stock-based
compensation expense, amortization of acquired intangibles resulting
from business combination, change in fair value of convertible preferred
stock warrant liability and collaboration and development expense. The
Company believes that these non-GAAP financial measures help analyze the
Company’s financial results, establish budgets and operational goals for
managing its business and to evaluate performance. The Company also
believe that the presentation of these non-GAAP financial measures
provides an additional tool for investors to use in comparing Aquantia’s
core business and results of operations over multiple periods with other
companies in the industry, many of which present similar non-GAAP
financial measures to investors. However, the non-GAAP financial
measures presented may not be comparable to similarly titled measures
reported by other companies due to differences in the way that these
measures are calculated. The non-GAAP financial measures presented
should not be considered as the sole measure of our performance and
should not be considered in isolation from, or as a substitute for,
comparable financial measures calculated in accordance with GAAP.
About Aquantia
Aquantia is a leader in the design, development and marketing of
advanced, high-speed communications ICs for Ethernet connectivity in the
Data Center, Enterprise Infrastructure, Access and Automotive markets.
Aquantia products are designed to cost-effectively deliver leading-edge
data speeds for use in the latest generation of communications
infrastructure to alleviate network bandwidth bottlenecks caused by the
growth of global IP traffic and in emerging and demanding applications
such as autonomous driving. Aquantia is headquartered in Silicon
Valley. For more information, visit www.aquantia.com.
(AQ-INV)
Forward-Looking Statements
Statements in the press release for the first quarter 2019 regarding the
Company, which are not historical facts, constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements may be identified
by terms such as “outlook,” “believe,” “expect,” “may,” “will,”
“provide,” “continue,” “could,” and “should,” and the negative of these
terms or other similar expressions. These statements include statements
relating to the deployment of the Company’s products and design wins
driving revenue growth throughout the year. These statements are subject
to significant risks and uncertainties and actual results could differ
materially from those projected. The Company cautions investors not to
place undue reliance on the forward-looking statements contained in this
release. These risks and uncertainties include, without limitation,
risks and uncertainties related to: the Company’s ability to achieve or
sustain profitable operations due to its history of losses and
accumulated deficit; the Company’s dependence on a limited number of
customers for a substantial portion of revenue and lack of long-term
purchase commitments therefrom; the Company’s ability to achieve design
wins in competitive selection processes; the Company’s ability to
develop new or enhanced products in a timely manner; the size and growth
potential of the markets that the Company targets and the Company’s
ability to compete therein; market demand for the Company’s products,
including by customers of its direct customers; reliance on third
parties to manufacture, assemble and test our products as well as their
ability to achieve cost and yield improvements; lengthy and expensive
qualification processes; product defects; the Company’s ability to
obtain and maintain intellectual property protection for its technology;
developments in regulation and industry standards in the United States
and other jurisdictions; and other risks inherent to the fabless
semiconductor business. For a discussion of these and other related
risks, please refer to the Company’s recent SEC filings which are
available on the SEC’s website at www.sec.gov.
These forward-looking statements are based on the Company’s expectations
and assumptions as of the date of this press release. Except as required
by law, the Company undertakes no duty or obligation to update any
forward-looking statements contained in this press release as a result
of new information, future events or changes in the Company’s
expectations.
AQUANTIA CORP. |
||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||
(in thousands, except per share amounts) |
||||||||
(Unaudited) |
||||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2019 | 2018 | |||||||
Revenue | $ | 17,022 | $ | 28,358 | ||||
Cost of revenue | 8,056 | 12,241 | ||||||
Gross profit | 8,966 | 16,117 | ||||||
Gross Profit Margin | 52.7 | % | 56.8 | % | ||||
Operating expenses | ||||||||
Research and development | 16,070 | 12,574 | ||||||
Sales and marketing | 2,719 | 2,287 | ||||||
General and administrative | 3,422 | 2,997 | ||||||
Total operating expenses | 22,211 | 17,858 | ||||||
Loss from operations | (13,245 | ) | (1,741 | ) | ||||
Other income (expense) | 368 | 248 | ||||||
Loss before income tax expenses | (12,877 | ) | (1,493 | ) | ||||
Provision for (benefit from) income taxes | 190 | (125 | ) | |||||
Net loss | $ | (13,067 | ) | $ | (1,368 | ) | ||
Net loss per share | ||||||||
Basic | $ | (0.37 | ) | $ | (0.04 | ) | ||
Diluted | $ | (0.37 | ) | $ | (0.04 | ) | ||
Weighted – average shares used in computing net income per share: | ||||||||
Basic | 35,158 | 33,495 | ||||||
Diluted | 35,158 | 33,495 | ||||||
AQUANTIA CORP. |
||||||||
RECONCILIATION OF GAAP NET LOSS |
||||||||
TO NON-GAAP NET LOSS |
||||||||
(in thousands, except per share amounts) |
||||||||
(Unaudited) |
||||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2019 | 2018 | |||||||
GAAP net loss | $ | (13,067 | ) | $ | (1,368 | ) | ||
Stock-based compensation expense: | ||||||||
Cost of revenue | 66 | 25 | ||||||
Research and development | 1,232 | 573 | ||||||
Sales and marketing | 350 | 111 | ||||||
General and administrative | 642 | 269 | ||||||
Total stock-based compensation expense | 2,290 | 978 | ||||||
Amortization of acquired intangibles resulting from business |
8 | 8 | ||||||
Non-GAAP net loss | $ | (10,769 | ) | $ | (382 | ) | ||
GAAP basic earnings per share | $ | (0.37 | ) | $ | (0.04 | ) | ||
Effect of non-GAAP adjustments on basic earnings per share | 0.06 | 0.03 | ||||||
Non-GAAP basic earnings per share | $ | (0.31 | ) | $ | (0.01 | ) | ||
GAAP diluted earnings per share | $ | (0.37 | ) | $ | (0.04 | ) | ||
Effect of non-GAAP adjustments on diluted earnings per share | 0.06 | 0.03 | ||||||
Non-GAAP diluted earnings per share | $ | (0.31 | ) | $ | (0.01 | ) | ||
Weighted – average shares used in computing net income per share: | ||||||||
Basic | 35,158 | 33,495 | ||||||
Diluted | 35,158 | 33,495 | ||||||
GAAP loss from operations | $ | (13,050 | ) | $ | (1,741 | ) | ||
Stock-based compensation expense | 2,290 | 978 | ||||||
Amortization of acquired intangibles resulting from business |
8 | 8 | ||||||
Non-GAAP loss from operations | $ | (10,752 | ) | $ | (755 | ) | ||
AQUANTIA CORP. | ||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
(in thousands) | ||||||||
March 31, | December 31, | |||||||
2019 | 2018 | |||||||
(unaudited) | (audited) | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 8,480 | $ | 6,684 | ||||
Short-term investments | 53,895 | 60,730 | ||||||
Accounts receivable, net | 10,350 | 16,927 | ||||||
Inventories | 17,015 | 14,474 | ||||||
Prepaid expenses and other current assets | 1,801 | 2,018 | ||||||
Total current assets | 91,541 | 100,833 | ||||||
Property and equipment, net | 11,211 | 9,225 | ||||||
Operating lease assets, net | 5,644 | – | ||||||
Intangible assets, net | 3,546 | 3,748 | ||||||
Other assets | 616 | 617 | ||||||
Total assets | $ | 112,558 | $ | 114,423 | ||||
Liabilities and shareholders’ equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 6,349 | $ | 5,495 | ||||
Accrued liabilities | 15,750 | 13,907 | ||||||
Operating lease liabilities, short-term | 839 | – | ||||||
Total current liabilities | 22,938 | 19,402 | ||||||
Operating lease liabilities, long-term | 6,251 | – | ||||||
Other long-term liabilities | 413 | 1,799 | ||||||
Total liabilities | 29,602 | 21,201 | ||||||
Stockholders’ equity: | ||||||||
Common stock | – | – | ||||||
Additional paid-in capital | 303,473 | 300,791 | ||||||
Accumulated comprehensive loss | (4 | ) | (123 | ) | ||||
Accumulated deficit | (220,513 | ) | (207,446 | ) | ||||
Total stockholders’ equity | 82,956 | 93,222 | ||||||
Total liabilities and stockholders’ equity | $ | 112,558 | $ | 114,423 | ||||
Contacts
Public Relations Contact:
Diane Vanasse
408-242-0027
[email protected]
Investor Relations Contact:
Deborah Stapleton
650-815-1239
[email protected]
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Humboldt
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia
SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.
The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.
Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.
“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”
Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”
About Humboldt Seed Company
Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.
For more information visit https://humboldtseedcompany.com/.
About Apollo Green
Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics.
For more information visit https://apollogreen.com/.
Media contact
Jaana Prall
[email protected]
Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE3 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace